The purpose of this study is to investigate the clinical correlates of the effects of the COVID-19 pandemic on patients with Functional movement disorder (FMD) and Parkinson s Disease (PD). Primary objectives: To evaluate the change in neurological symptoms domain of the survey between pre and post-COVID 19 in FMD and PD patients. Secondary objectives: - To evaluate the change in total score of the survey between pre and post COVID 19 in FMD and PD patients - To evaluate the change in other symptom domains of the survey between pre and post COVID 19 in FMD and PD patients. Domains include: Mood/Energy, sleep, symptoms of abnormal movements related or unrelated to primary disease, physical health and exercise related change Exploratory objectives: - To evaluate whether there is a modifying effect of disease group in the changes in total score or symptom domains - To evaluate whether there is a relationship between disease severity and changes in total score or symptom domains - To evaluate whether there is a correlation between changes across symptom domains - To evaluate whether there is a correlation in raw score across symptom domains within each period Research Methods: Data will be solely collected through the use of online instruments via CiSTAR as a designed questionnaire. Questionnaire items A questionnaire aimed at determining the effects of the COVID 19 pandemic and subsequent isolation on functional state of patients with FMD and PD. The questionnaire items include: Items investigating Mood/Energy before and after COVID 19 out break Items investigating Sleep habits before and after COVID 19 out break Items investigating Neurological symptoms before and after COVID 19 out break Items investigating daily functioning before and after COVID 19 out break Items investigating Exercise habits before and after COVID 19 out break No questionnaire items will be actionable , which are items that would identify an imminent risk for participant safety requiring urgent and immediate medical or psychiatric
The purpose of this study is to investigate the clinical correlates of the effects of the
COVID-19 pandemic on patients with Functional movement disorder (FMD) and Parkinson s Disease
(PD).
Primary objectives:
To evaluate the change in neurological symptoms domain of the survey between pre and
post-COVID 19 in FMD and PD patients.
Secondary objectives:
- To evaluate the change in total score of the survey between pre and post COVID 19 in FMD
and PD patients
- To evaluate the change in other symptom domains of the survey between pre and post COVID
19 in FMD and PD patients. Domains include: Mood/Energy, sleep, symptoms of abnormal
movements related or unrelated to primary disease, physical health and exercise related
change
Exploratory objectives:
- To evaluate whether there is a modifying effect of disease group in the changes in total
score or symptom domains
- To evaluate whether there is a relationship between disease severity and changes in
total score or symptom domains
- To evaluate whether there is a correlation between changes across symptom domains
- To evaluate whether there is a correlation in raw score across symptom domains within
each period
Research Methods:
Data will be solely collected through the use of online instruments via CiSTAR as a designed
questionnaire.
Questionnaire items
A questionnaire aimed at determining the effects of the COVID 19 pandemic and subsequent
isolation on functional state of patients with FMD and PD.
The questionnaire items include:
Items investigating Mood/Energy before and after COVID 19 out break
Items investigating Sleep habits before and after COVID 19 out break
Items investigating Neurological symptoms before and after COVID 19 out break
Items investigating daily functioning before and after COVID 19 out break
Items investigating Exercise habits before and after COVID 19 out break
No questionnaire items will be actionable , which are items that would identify an imminent
risk for participant safety requiring urgent and immediate medical or psychiatric
- INCLUSION CRITERIA:
1. (for FMD subjects only) Clinical diagnosis of Functional movement disorder as
confirmed by a movement disorders specialist in subjects previously enrolled in
protocol 07-N-0190
2. (for PD subjects only) Clinical diagnosis of Parkinson s Disease as confirmed by
a movement disorders specialist in subjects previously enrolled in protocol
01-N-0206.
3. Able to give informed consent
4. Male or female, age 18 and above
5. Have access to the internet in order to fill out the survey
6. Have enough fluency in English to be able to read the consent form and take the
survey in English
EXCLUSION CRITERIA:
N/A
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States
Mark Hallett, M.D., Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)